DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Tolnaftate

Tolnaftate

  • The National Drugs List

    The National Drugs List

  • Conazoles

    Conazoles

  • NINDS Custom Collection II

    NINDS Custom Collection II

  • Us Anti-Doping Agency

    Us Anti-Doping Agency

  • Therapeutic Class Overview Antifungals, Topical

    Therapeutic Class Overview Antifungals, Topical

  • Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr

    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr

  • Malta Medicines List April 08

    Malta Medicines List April 08

  • Sacubitril/Valsartan

    Sacubitril/Valsartan

  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

    Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

  • Nebraska Medicaid Preferred Drug List with Prior Authorization Criteria May 2018 P&T Changes Effective July 19, 2018 Highlights Indicate P&T Changes

    Nebraska Medicaid Preferred Drug List with Prior Authorization Criteria May 2018 P&T Changes Effective July 19, 2018 Highlights Indicate P&T Changes

  • Application of Marsplines and Descriptors Encoded in SMILES String

    Application of Marsplines and Descriptors Encoded in SMILES String

  • Luzu (Luliconzole)

    Luzu (Luliconzole)

  • (12) United States Patent (10) Patent No.: US 7,198,800 B1 K0 (45) Date of Patent: Apr

    (12) United States Patent (10) Patent No.: US 7,198,800 B1 K0 (45) Date of Patent: Apr

  • Compounding for Scalp Disorders and Conditions

    Compounding for Scalp Disorders and Conditions

  • Dermatophyte Infections YVONNE M

    Dermatophyte Infections YVONNE M

  • Antifungal Drugs and the Risk of Selected Birth Defects.91.E1- Am J Obstet Gynecol 2008;198:1 191.E7

    Antifungal Drugs and the Risk of Selected Birth Defects.91.E1- Am J Obstet Gynecol 2008;198:1 191.E7

  • Method and Composition for Testosterone Transdermal

    Method and Composition for Testosterone Transdermal

  • Mdwise Formulary Introduction – Healthy Indiana Plan State (HIP State)

    Mdwise Formulary Introduction – Healthy Indiana Plan State (HIP State)

Top View
  • Orally Active Tolciclate and Tolnaftate
  • Ketoconazole in Griseofulvin-Resistant Dermatophytosis
  • Uncovering New Drug Properties in Target-Based Drug-Drug Similarity Networks
  • Medication Coverage Policy
  • Managing Athlete's Foot
  • Long-Term Care Drug Database System: Drugs by NDC Class Code, Drug Code and Name
  • 548 Antifungals
  • (Athlete's Foot)? Orally Administered Antifungal Agents Are Expensive EVIDENCE-BASED ANSWER and Can Have Systemic Side Effects
  • Examples of Prohibited and Permitted Substances And
  • Therapeutic Drug Class
  • Management of Drug Overdose and Poisoning
  • 2019 LPGA Permitted Medications List
  • Medication Guide 2012
  • Tolnaftate Therapy of Mycotic Infections
  • Fungal Infections
  • US5519059.Pdf
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0101538A1 Larnier Et Al
  • Provider Bulletin 18-11


© 2024 Docslib.org    Feedback